Almac Group, the global contract development and manufacturing organisation, is delighted to have won the coveted Chartered Institute of Marketing (CIM) Marketing in Life Sciences award.
This annual event aims to recognise and celebrate outstanding marketing by organisations, individuals and teams with a glittering awards ceremony - this year's event took place in the Europa Hotel, Belfast on Thursday 10th November.
Almac received the award for demonstrating its marketing excellence in the Asia Pacific region - a key market for Almac with the market growth in clinical trials forecasted to grow. Almac currently has almost 30 employees in its Singapore facility with a further 9 based in Japan. Since the official opening of its Singapore facility in 2014, significant efforts have been made between the UK and Asia Pacific's business development teams, supported by the head office marketing team, to develop and grow Almac's brand awareness within this key market. The Asia Pacific region comes with its own market challenges (language barriers, unique cultures), however, the marketing team of Almac worked hard to position Almac as a thought leader providing a unique set of differentiated service offerings.
An independent panel of recognised and expert individuals in the Marketing sector judged each entry and assessed the innovation illustrated by the short-listed marketers who are at the cutting edge of their profession. Almac were delighted to be chosen as the company which clearly demonstrated its high standard of quality and integrity, vital to its marketing success.
Jonathan Calderwood, Commercial Development Director, Almac Group commented:
We are delighted that our Asia Pacific Marketing Campaign won this CIM Marketing in Life Sciences award. This is a great achievement and demonstrates the capability, expertise and collaboration that our marketing and business development teams have. This recognition is a much deserved testament to their dedication and hard work.
About Almac Group
'Partnering to Advance Human Health'
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).